Loan & DebtJul 1, 2026, 04:01 AM
Alvotech Secures $75M Term Loan, Access to $240M New Capital
AI Summary
Alvotech announced an amendment to its credit agreement, securing an additional $75 million term loan facility led by GoldenTree Asset Management. This financing, combined with a recent $165 million equity capital raise, provides the company with access to $240 million in new capital. The funds will be used to strengthen Alvotech's financial position, advance its biosimilar pipeline, support product launches, and expand global commercial operations.
Key Highlights
- Alvotech secured a $75 million additional term loan facility.
- The new loan matures on December 31, 2027, with a 12.50% interest rate.
- This follows a recent $165 million equity capital raise.
- Total new capital access, including the undrawn loan, is $240 million.
- Funds will support R&D pipeline execution and global product launches.
- The financing expands an existing credit agreement, adding to a $100 million term loan from December 2025.
Price Impact
More from ALVO